1. Home
  2. IINN vs VNRX Comparison

IINN vs VNRX Comparison

Compare IINN & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inspira Technologies Oxy B.H.N. Ltd.

IINN

Inspira Technologies Oxy B.H.N. Ltd.

N/A

Current Price

$0.58

Market Cap

35.3M

Sector

Health Care

ML Signal

N/A

Logo VolitionRX Limited

VNRX

VolitionRX Limited

N/A

Current Price

$0.20

Market Cap

31.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IINN
VNRX
Founded
2018
N/A
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.3M
31.9M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
IINN
VNRX
Price
$0.58
$0.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$2.00
$2.50
AVG Volume (30 Days)
388.9K
1.8M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
N/A
N/A
Revenue
N/A
$1,233,511.00
Revenue This Year
N/A
$68.22
Revenue Next Year
$9,715.95
$382.75
P/E Ratio
N/A
N/A
Revenue Growth
N/A
59.10
52 Week Low
$0.40
$0.17
52 Week High
$1.65
$0.94

Technical Indicators

Market Signals
Indicator
IINN
VNRX
Relative Strength Index (RSI) 33.20 39.10
Support Level $0.55 $0.17
Resistance Level $1.12 $0.27
Average True Range (ATR) 0.03 0.02
MACD 0.01 0.00
Stochastic Oscillator 22.33 31.96

Price Performance

Historical Comparison
IINN
VNRX

About IINN Inspira Technologies Oxy B.H.N. Ltd.

Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: